1. Home
  2. FAMI vs TRIB Comparison

FAMI vs TRIB Comparison

Compare FAMI & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

HOLD

Current Price

$1.26

Market Cap

17.0M

ML Signal

HOLD

TRIB

Trinity Biotech plc

HOLD

Current Price

$0.71

Market Cap

14.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAMI
TRIB
Founded
2015
1992
Country
China
Ireland
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.0M
14.0M
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
FAMI
TRIB
Price
$1.26
$0.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.0K
165.6K
Earning Date
08-04-2025
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.51
Revenue Next Year
N/A
$13.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$0.50
52 Week High
$2.22
$3.44

Technical Indicators

Market Signals
Indicator
FAMI
TRIB
Relative Strength Index (RSI) 50.38 58.69
Support Level $1.20 $0.71
Resistance Level $1.39 $0.80
Average True Range (ATR) 0.10 0.06
MACD 0.00 0.02
Stochastic Oscillator 37.50 95.90

Price Performance

Historical Comparison
FAMI
TRIB

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe and the Middle East under the Forasen and Farmmi brands.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: